FDA granted Fast Track designation for Tivic Health Systems' TLR5 agonist Entolimod, and Lisa Wolf assumed CFO role.

1 report, 0 independent Updated Jul 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

FDA

Keep exploring

Part of

FDA granted Fast Track and Orphan Drug designation for Tivic Health Systems, Inc. following company announcements regarding results from Fremont on August 7, 2025. All 2 developments

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Jul 8Unknown outlet